CytomX Therapeutics, Inc. CTMX
2.04 USD 0.00 (+0.00%)
Regular-session close
2.04 0.00 0.00%
After hours · Nov 13, 4:01 PM ET
1.96 Day range 2.13
1.98 52-week range 6.75
- YTD
- -52.11%
- 1 year
- -47.15%
News
seekingalpha.com CytomX Therapeutics: Competitors Impress, Now Its Cytomx's Time To Shine CytomX Therapeutics is approaching a high-impact readout from its monotherapy work with Varseta-M in colorectal cancer in January 2027. Recent dosing adjustments and steroid prophylaxis have reduced…
benzinga.com JP Morgan Maintains Overweight on CytomX Therapeutics, Raises Price Target to $12 JP Morgan analyst Anupam Rama maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and raises the price target from $11 to $12.
benzinga.com Wedbush Maintains Outperform on CytomX Therapeutics, Raises Price Target to $12 Wedbush analyst Robert Driscoll maintains CytomX Therapeutics (NASDAQ:CTMX) with a Outperform and raises the price target from $11 to $12.
benzinga.com CytomX Therapeutics Q3 2026 Earnings Call Transcript CytomX Therapeutics (NASDAQ:CTMX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com CytomX Therapeutics Q3 EPS $(0.09) Beats $(0.10) Estimate, Sales $1.688M Miss $4.925M Estimate CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 0 percent. This is unchanged from the same period last year.…
benzinga.com JP Morgan Maintains Overweight on CytomX Therapeutics, Lowers Price Target to $11 JP Morgan analyst Anupam Rama maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and lowers the price target from $12 to $11.- benzinga.com Guggenheim Maintains Buy on CytomX Therapeutics, Lowers Price Target to $14 Guggenheim analyst Michael Schmidt maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $15 to $14.
benzinga.com CytomX Therapeutics Q2 EPS $(0.09) Beats $(0.11) Estimate, Sales $1.418M Miss $12.308M Estimate CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. The company reported quarterly sales of $1.418…
benzinga.com CytomX Expands Collaboration And Licensing Agreement With Regeneron To Create Conditionally-Activated Bispecific Cancer Therapies Utilizing CytomX's Probody Therapeutic Platform And Regeneron's Veloci-Bi Bispecific Antibody Development Platform - Expanded collaboration builds upon research momentum in developing next-generation bispecific immunotherapies using CytomX's PROBODY® and Regeneron's Veloci-Bi® platforms -- CytomX to receive $37…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Crude Oil Down 4%; Dollar Tree Earnings Top Views 
benzinga.com Nebius Group, CytomX Therapeutics, National Storage Affiliates Trust And Other Big Stocks Moving Higher On Monday Dow Jones index up 500 points; Nebius Group NV shares rise 12.7% on AI agreement with Meta Platforms; several other stocks record gains.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com Market-Moving News for March 16th NBIS: 17% | Nebius Announced 5-Year $12B AI Infrastructure Agreement With Meta To Provide Dedicated Capacity Across Multiple Locations Using NVIDIA Vera Rubin Platform Starting Early 2027 CTMX: 70%
benzinga.com Earnings Scheduled For March 16, 2026 
benzinga.com Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session 
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
benzinga.com Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Earnings Scheduled For May 12, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 6, 2025
- benzinga.com Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- benzinga.com Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
- benzinga.com Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top…
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
- benzinga.com Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers
- benzinga.com Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.
benzinga.com Earnings Scheduled For March 27, 2023 Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for…- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 283 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 49 companies set new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 Upgrades
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For May 5, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 435 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 784 companies set new 52-week lows.